Showing results (141-150 of 180) with videos related to

Sort By:
Pageof 18
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 1, 1997
Cost-effectiveness of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patientsP S McKinnon, J A Paladino, M L Grayson, et al.
The Medical Journal of Australia|January 5, 2002
Treatment failure due to methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycinP B Ward, P D Johnson, E A Grabsch, et al.
Antimicrobial Agents and Chemotherapy|April 28, 2005
Molecular characterization of vanB elements in naturally occurring gut anaerobesS A Ballard, K K Pertile, M Lim, et al.
Lancet (London, England)|March 27, 2001
Enterococcal vanB resistance locus in anaerobic bacteria in human faecesT P Stinear, D C Olden, P D Johnson, et al.
Antimicrobial Agents and Chemotherapy|January 9, 2008
High rates of fecal carriage of nonenterococcal vanB in both children and adultsM Graham, S A Ballard, E A Grabsch, et al.
Lancet (London, England)|July 31, 2001
Linezolid resistance in a clinical isolate of Staphylococcus aureusS Tsiodras, H S Gold, G Sakoulas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2001
Prolonged colonization with vancomycin-resistant Enterococcus faecium in long-term care patients and the significance of "clearance"L R Baden, W Thiemke, A Skolnik, et al.
Journal of Clinical Microbiology|January 1, 2009
Utility of peptide nucleic acid fluorescence in situ hybridization for rapid detection of Acinetobacter spp. and Pseudomonas aeruginosaA Y Peleg, Y Tilahun, M J Fiandaca, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1989
Treatment of experimental endocarditis caused by a beta-lactamase-producing strain of Enterococcus faecalis with high-level resistance to gentamicinR G Hindes, S H Willey, G M Eliopoulos, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1990
Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facilityL B Rice, S H Willey, G A Papanicolaou, et al.
Pageof 18